Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update

Palatin Technologies (PTN) reported $13.2M in FY 2026 revenue, up from zero, with a net loss of $8.4M. Key revenue sources included Boehringer Ingelheim ($9.4M) and Altanispac ($3.8M). Cash reserves grew to $7.5M. The company plans to advance MC4R agonist therapies for obesity, with clinical trials expected in 2027. Management expressed concerns about liquidity, stating existing cash may not last 12 months.

Albertsons Companies Inc. (ACI) withdrew its financial outlook after Q2 sales fell 0.1% to $18.9B and profit declined. Executive Chair Margaret Whitman cited disappointing results and called for faster cost cuts and price reductions. ACI stock is down 23% this year, on track for its worst annual performance since 2022.

Goldman Sachs (GS) reported Q3 2026 net revenues of $18.7B, with record advisory revenues and 72% YoY growth in equities. Asset management revenues rose 14% YoY. Challenges include geopolitical tensions, inflation, and credit quality concerns. CEO David Solomon addressed succession plans, market structure, and AI financing risks. The company maintains a strong capital buffer and expects active Q4 trading. GS's durable revenues now represent 45% of YTD revenues.

Johnson & Johnson (JNJ) reported Q3 2026 operational sales growth of 6%, exceeding expectations. Innovative Medicine grew 7.9%, with key products like TREMFYA and CARVYKTI showing strong sales. The company raised its full-year guidance. However, MedTech grew only 2.5%, and talc litigation expenses impacted GAAP earnings. JNJ expects future growth from pipeline advancements and strategic investments.

Citigroup reported its best Q3 revenue in a decade, but faced challenges like flat consumer cards revenue and expected market revenue declines. Expenses rose 3%, and cost of credit was $2.6 billion. CEO Jane Fraser and CFO Gonzalo Luchetti reaffirmed confidence in exceeding the full-year ROTCE target of above 11% and reiterated near-term targets of 11% to 13% for 2027-2028. The firm is investing in technology and marketing, with $3 billion in buybacks in Q3.

Domino's Pizza Inc (DPZ) reported Q3 2026 earnings, lowering guidance for US and international same-store sales growth, net new store openings, and global retail sales growth due to macroeconomic pressures and franchisee profitability challenges. CEO Joe Jordan discussed strategies to balance promotions, improve ticket growth, and manage delivery channels. The company expects continued pressure on franchisee profits and store development until conditions improve.